Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.
Bray
G
G
Baxter Biotech., Hyland Division, Glendale, CA.
D000328:Adult; D000818:Animals; D016466:CHO Cells; D002648:Child; D006224:Cricetinae; D005169:Factor VIII / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007668:Kidney; D011994:Recombinant Proteins / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D014162:Transfection
D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII